Imetelstat: Finally a disease-modifying treatment for lower-risk myelodysplastic syndromes?

Fatemeh Majidi1, Norbert Gattermann1

  • 1Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.

Med (New York, N.Y.)
|March 9, 2024
PubMed